Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.730
+0.050 (1.87%)
At close: Feb 5, 2026
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 521.15 million as of February 5, 2026. Its market cap has decreased by -22.74% in one year.
Market Cap
521.15M
Enterprise Value
790.03M
Revenue
741.27M
Ranking
n/a
PE Ratio
16.01
Stock Price
2.73
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 521.15M, a decrease of -24.50%. That is a compound annual growth rate of -5.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 511.60M | -2.55% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | 690.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 11.26B |
| Integral Diagnostics | 972.78M |
| Healius | 671.67M |
| Monash IVF Group | 276.64M |
| Microba Life Sciences | 52.98M |
| Cryosite | 51.74M |
| INOVIQ | 49.27M |
| Rhythm Biosciences | 49.06M |